Howland Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.74M Sell
3,121
-254
-8% -$260K 0.14% 95
2026
Q1
$3.1M Buy
3,375
+69
+2% +$70K 0.12% 96
2025
Q4
$3.55M Buy
3,306
+272
+9% +$260K 0.14% 90
2025
Q3
$2.31M Sell
3,034
-141
-4% -$105K 0.09% 107
2025
Q2
$2.48M Sell
3,175
-233
-7% -$181K 0.1% 102
2025
Q1
$2.81M Sell
3,408
-176
-5% -$146K 0.13% 91
2024
Q4
$2.77M Sell
3,584
-255
-7% -$211K 0.12% 90
2024
Q3
$3.4M Sell
3,839
-693
-15% -$623K 0.15% 85
2024
Q2
$4.1M Sell
4,532
-78
-2% -$62.4K 0.2% 73
2024
Q1
$3.59M Sell
4,610
-252
-5% -$179K 0.17% 78
2023
Q4
$2.83M Sell
4,862
-468
-9% -$273K 0.15% 82
2023
Q3
$2.86M Sell
5,330
-495
-8% -$255K 0.17% 82
2023
Q2
$2.73M Buy
5,825
+5
+0.1% +$2.1K 0.16% 84
2023
Q1
$2M Sell
5,820
-787
-12% -$265K 0.12% 92
2022
Q4
$2.42M Sell
6,607
-333
-5% -$118K 0.15% 87
2022
Q3
$2.24M Buy
6,940
+1,049
+18% +$332K 0.14% 85
2022
Q2
$1.91M Buy
5,891
+1,403
+31% +$421K 0.12% 89
2022
Q1
$1.29M Buy
4,488
+170
+4% +$43.8K 0.07% 103
2021
Q4
$1.19M Buy
4,318
+25
+0.6% +$6.34K 0.06% 105
2021
Q3
$992K Hold
4,293
0.05% 119
2021
Q2
$985K Hold
4,293
0.05% 122
2021
Q1
$802K Buy
4,293
+230
+6% +$45K 0.04% 132
2020
Q4
$686K Sell
4,063
-132
-3% -$19.7K 0.04% 134
2020
Q3
$621K Sell
4,195
-30
-0.7% -$4.64K 0.04% 136
2020
Q2
$694K Hold
4,225
0.05% 125
2020
Q1
$586K Sell
4,225
-274
-6% -$37.6K 0.05% 126
2019
Q4
$591K Sell
4,499
-115
-2% -$13.3K 0.04% 143
2019
Q3
$516K Buy
4,614
+807
+21% +$89.8K 0.04% 149
2019
Q2
$422K Sell
3,807
-900
-19% -$106K 0.03% 152
2019
Q1
$611K Sell
4,707
-475
-9% -$57.8K 0.05% 135
2018
Q4
$600K Buy
5,182
+114
+2% +$12.7K 0.06% 128
2018
Q3
$544K Sell
5,068
-121
-2% -$12.1K 0.04% 147
2018
Q2
$443K Hold
5,189
0.04% 163
2018
Q1
$401K Buy
5,189
+197
+4% +$15.9K 0.03% 169
2017
Q4
$422K Hold
4,992
0.03% 166
2017
Q3
$427K Buy
4,992
+120
+2% +$9.84K 0.04% 164
2017
Q2
$401K Sell
4,872
-200
-4% -$16.3K 0.03% 165
2017
Q1
$427K Buy
5,072
+195
+4% +$15.6K 0.04% 160
2016
Q4
$359K Hold
4,877
0.03% 166
2016
Q3
$391K Buy
4,877
+132
+3% +$10.6K 0.04% 154
2016
Q2
$374K Hold
4,745
0.04% 156
2016
Q1
$342K Buy
4,745
+5
+0.1% +$378 0.03% 160
2015
Q4
$399K Sell
4,740
-4
-0.1% -$332 0.04% 157
2015
Q3
$397K Sell
4,744
-120
-2% -$10.1K 0.04% 156
2015
Q2
$406K Hold
4,864
0.04% 152
2015
Q1
$353K Sell
4,864
-192
-4% -$13.7K 0.04% 159
2014
Q4
$349K Buy
5,056
+500
+11% +$33.8K 0.03% 163
2014
Q3
$295K Buy
4,556
+800
+21% +$50.6K 0.03% 165
2014
Q2
$234K Buy
3,756
+232
+7% +$13.8K 0.02% 174
2014
Q1
$207K Buy
+3,524
New +$197K 0.02% 175
2013
Q4
Sell
-4,774
Closed -$240K 188
2013
Q3
$240K Buy
+4,774
New +$250K 0.03% 162

Other funds holding LLY

Howland Capital Management's LLY Position: Q2 2026 in Review

Howland Capital Management reduced its Eli Lilly (LLY) stake by 7.5% in Q2 2026, selling an estimated $260K and leaving 3,121 shares worth $3.74M. The position accounts for 0.14% of the portfolio, ranked #95.

Howland Capital Management first reported a position in LLY in Q3 2013 and has held it in 51 quarters since. The position peaked at $4.1M in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Howland Capital Management held 3,121 shares of Eli Lilly worth $3.74M as of Q2 2026.
  • Howland Capital Management sold 254 Eli Lilly shares in Q2 2026, an estimated $260K.
  • Eli Lilly made up 0.14% of Howland Capital Management's portfolio in Q2 2026, its #95 holding.
  • Howland Capital Management first reported a position in Eli Lilly in Q3 2013 and has held it in 51 quarters since.
  • Howland Capital Management's Eli Lilly position peaked at $4.1M in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.